Suraksha Diagnostic Q2 2026: Unaudited Results, New CFO, & Upcoming Corporate Action
Suraksha Diagnostic Limited unveils a quarter review: new CFO, unaudited results, 12.9 bn market cap, and a looming 15 Sep corporate action—what this means for investors.
3 minutes to read